Reproductive Disorder Clinical Trial
— EMCIMOOfficial title:
Do the Morphokinetic Parameters of Early Embryonic Development Have an Interest in the Choice of the Embryo to be Transferred and Improve Birth Rates in Vitro Fertilization
Verified date | January 2019 |
Source | University Hospital, Rouen |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In France, nearly 3% of children are conceived by the technique of Assisted Reproductive
Medicine, of which nearly 70% by in vitro fertilization (IVF). The rates of clinical
pregnancy by oocyte retrieval or embryo transfer have not changed much. The use of
mono-embryo transfer reduces the risk of multiple pregnancies and associated obstetric
complications. The choice of embryo to transfer or freeze is a key element in improving the
chances of success of IVF. It is usually based on conventional morphological criteria
(reference method) that are punctual, qualitative and subjective. However, embryo morphology
at early stages has little predictive value for obtaining a late-stage embryo and its chances
of implantation. The recent use of time-lapse technology during embryonic culture makes it
possible to associate morphological criteria with continuous monitoring of the kinetics of
embryonic development. The choice of the embryo to be transferred is then made according to
morphokinetic criteria (conventional morphological criteria to which are added the data of
the kinetics of embryonic development).
Two recent retrospective studies give contradictory results, the first shows higher birth
rates in the group of embryos selected according to conventional morphological criteria, the
second concludes that morphokinetic analysis is superior. Morphokinetic criteria would also
be more objective and reproducible. However, the use of morphokinetic parameters remains
controversial in the literature.
Status | Not yet recruiting |
Enrollment | 520 |
Est. completion date | March 1, 2026 |
Est. primary completion date | March 1, 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 59 Years |
Eligibility |
Inclusion Criteria: 1. For the couple: - Couple whose two members are 18 years old and over, - Couple whose two members are affiliated to a social security scheme, - Couple whose two members read and understood the newsletter and signed the consent form for their participation in this research. 2. For the conditions of realization of the ICSI attempt: - Couple supported for a 1st or 2nd attempt at in vitro fertilization with sperm microinjection (ICSI) for male infertility, - In vitro fertilization attempt performed with micro-injection of fresh ejaculated spermatozoa. 3. For the man: - Couple whose man has an alteration of at least one of the sperm parameters according to the WHO (WHO, 2010) for the number, concentration, vitality, mobility or morphology according to the modified David classification (Auger and Eustache, 2000). Exclusion Criteria: 1. For the couple: - Couple whose wife is under 18 and over 42 and / or the male is under 18 and over 59 - Couple already included in the protocol "EMCIMO" for a previous attempt, - Couple of which one or both members is deprived by an administrative or judicial decision or subject to a legal measure of protection of the majors (safeguard of justice or tutelage or curatorship), - Couple where one or both members do not speak or understand French. 2. For the conditions of realization of the ICSI attempt: - In vitro fertilization attempt with the micro-injection of testicular spermatozoa, epididymal, previously frozen or resulting from a retrograde ejaculation. 3. For the man: - Severe oligozoospermia (<100,000 spermatozoa / ejaculate). |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Rouen |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The primary endpoint of this study will be the live birth rate by fresh embryo transfer(s). | 36 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05788822 -
MVA to Improve the Pregnancy Outcome in Aged Infertility Women With Assisted Reproductive Technology
|
N/A | |
Recruiting |
NCT05971849 -
Dampening the Reproductive Axis With Continuous Kisspeptin
|
Phase 1 | |
Terminated |
NCT05901467 -
Recall by Genotype: Neuropeptide Stimulation
|
Phase 1 | |
Completed |
NCT03922087 -
No-worry Baby Project
|
||
Active, not recruiting |
NCT05866484 -
Testicular Sperm Aspiration (TESA) vs. Microfluidic Sperm Separation (MSS)
|
||
Not yet recruiting |
NCT06357208 -
IMPACT OF BREATH CONTROL AND RETENTION ON PATIENT STRESS. E.S IN MEDICALLY ASSISTED REPRODUCTION BREATH HOLD TO BREATH BETTER PROGRAM
|
N/A | |
Recruiting |
NCT03317548 -
A Comparison of Clinical Outcomes of Warmed Embryo Vitrified at 2PN Stage and Fresh Embryo Transfers
|
N/A | |
Suspended |
NCT05506800 -
Guangzhou Women's Health Cohort Study (GWHCS)
|
||
Completed |
NCT02341365 -
Vitamin D Influence on Oocyte Donation
|
N/A | |
Recruiting |
NCT05971836 -
The Molecular Basis of Inherited Reproductive Disorders
|
||
Completed |
NCT04854707 -
An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data
|
||
Completed |
NCT04361292 -
Ejaculatory Abstinence in IUI Cycles
|
N/A | |
Completed |
NCT03065114 -
Retrospective Study on Clinical Results of Preimplantation Genetic Screening at Different Embryo Stage
|
N/A |